NCT04588025View on ClinicalTrials.gov

Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

NARecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Pancreatic Cancer
Interventions
DEVICE

Point-of-care Portable Perfusion Phantom, P4

P4 is a perfusion phantom developed by Dr. Harrison Kim that can significantly reduce variation in quantitating perfusion of human abdominal tissues across MRI scanners.

Trial Locations (2)

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER